Prot #AR-301-002: A Randomized Double-blind Placebo-controlled Multicenter Phase 3 Study of Efficacy and Safety of AR-301 as Adjunct Therapy to Antibiotics in the Treatment of Ventilator-Associated Pneumonia (VAP) Caused by S. aureus

Project: Research project

Project Details

StatusActive
Effective start/end date3/9/203/9/23

Funding

  • Pharm-Olam International Ltd. (Prot #AR-301-002)
  • Aridis Pharmaceuticals, Inc. (Prot #AR-301-002)